TD Cowen lifts MicroStrategy target to $400 on quicker BTC per-share gains and $1.5B accretive debt buys
TD Cowen raised its MicroStrategy target to $400, citing faster bitcoin per-share growth and $1.5B of accretive debt repurchases. Here’s why that capital strategy can matter for MSTR.

Because Bitcoin
May 20, 2026
TD Cowen moved its price target on MicroStrategy (MSTR) to $400, flagging two drivers: a faster rise in bitcoin owned per share and $1.5 billion of accretive debt repurchases. The headline reads simple, but the engine under it is capital structure done with intent.
I’m focused on the second pillar—accretive deleveraging—because it quietly reshapes equity optionality. When a company retires debt below intrinsic value or trims high‑cost liabilities with cheap capital, it reduces claims ahead of equity and can lift net asset value per share. For a stock that many investors treat as a leveraged bitcoin proxy, shrinking debt while growing BTC per share creates a cleaner, more convex exposure to the underlying asset.
Why this matters for MSTR’s equity math: - Accretive repurchases retire obligations that otherwise siphon future cash or upside, improving per‑share economics without needing a higher BTC price. - Lower leverage can reduce forced‑seller risk during drawdowns, which often supports a tighter spread between equity value and the market value of BTC holdings. - As BTC per share accelerates, dilution fears get offset by the rising claim on on-chain assets per unit of equity. That ratio drives how the market handicaps MSTR versus simply holding spot BTC.
There’s a psychological layer here too. Equity investors in crypto proxies often pay for simplicity and liquidity. If they believe management can buy bitcoin through cycles and buy back debt opportunistically—without tripping liquidity covenants or relying on aggressive timing—they tend to reward that discipline with a higher multiple relative to net BTC value. TD Cowen’s call leans into that narrative: faster accumulation per share plus accretive deleveraging tightens the story.
What I’m watching next: - Pace versus quality of accumulation. “Faster” BTC per-share growth is constructive only if funding stays prudent and the share count doesn’t outgrow asset additions. - Liability mix and maturity profile. Accretive repurchases today are only as valuable as the residual cost of capital and refinancing windows tomorrow. - Stock-to-BTC basis. When MSTR trades at a premium or discount to its implied BTC per share, that basis reflects confidence in execution and balance sheet durability. Effective deleveraging can narrow volatility in that basis. - Execution cadence. $1.5 billion is a real signal. Repeating that playbook at the right points in the cycle can compound per-share value; pressing it at the wrong time can impair flexibility.
The ethical and governance read-through isn’t trivial. Running a corporate balance sheet as a bitcoin accumulator places equity upside and balance sheet risk on different constituencies than a spot ETF would. Accretive debt repurchases suggest management is not just adding BTC, but also cleaning up claims senior to common holders—bondholders who sold did so willingly, but retail equity holders still rely on clear disclosures, sober risk management, and restraint when the market invites excess.
Net-net, the path TD Cowen points to is straightforward: improve the claim per share on BTC while reducing leverage drag. If that continues, the equity can justify a higher target without needing heroic assumptions on bitcoin’s trajectory—though, as always in this market, the trajectory will likely set the tempo.
